Overview
Also known as:
FDA & Trial Timeline
4 eventsUniversity Hospital Regensburg
University of California, San Francisco — PHASE2
Hackensack Meridian Health
VITRAKVI: FDA approved
VITRAKVI® is indicated for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation; are metastatic or where surgical resection is likely to result in severe morbidity; and have no satisfactory alternative treatments or that have progressed following treatment.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableVITRAKVI
VITRAKVI� is indicated for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mu…
VITRAKVI� is indicated for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation; are metastatic or where surgical resection is likely to result in severe morbidity; and have no satisfactory alternative treatments or that have progressed following treatment.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Embryonal tumor with multilayered rosettes.
Community
No community posts yet. Be the first to share your experience with Embryonal tumor with multilayered rosettes.
Start the conversation →Latest news about Embryonal tumor with multilayered rosettes
Disease timeline:
New recruiting trial: Embryonal Tumor With Multilayered Rosettes
A new clinical trial is recruiting patients for Embryonal tumor with multilayered rosettes
New recruiting trial: CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
A new clinical trial is recruiting patients for Embryonal tumor with multilayered rosettes
New recruiting trial: Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
A new clinical trial is recruiting patients for Embryonal tumor with multilayered rosettes
New recruiting trial: A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
A new clinical trial is recruiting patients for Embryonal tumor with multilayered rosettes
New recruiting trial: DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
A new clinical trial is recruiting patients for Embryonal tumor with multilayered rosettes
New recruiting trial: Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
A new clinical trial is recruiting patients for Embryonal tumor with multilayered rosettes
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Embryonal tumor with multilayered rosettes
Are there clinical trials for Embryonal tumor with multilayered rosettes?
Yes — 2 recruiting clinical trials are currently listed for Embryonal tumor with multilayered rosettes on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Embryonal tumor with multilayered rosettes?
25 specialists and care centers treating Embryonal tumor with multilayered rosettes are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Embryonal tumor with multilayered rosettes?
1 patient support program are currently tracked on UniteRare for Embryonal tumor with multilayered rosettes. See the treatments and support programs sections for copay assistance, eligibility, and contact details.